Nesher Pharmaceuticals USA LLC

Avadel is a biopharmaceutical company dedicated to transforming medicines to enhance the quality of life for patients. Their innovative product, LUMRYZ, has been approved by the FDA as the first and only once-at-bedtime oxybate for treating cataplexy or excessive daytime sleepiness in patients aged 7 and older with narcolepsy. With a strong focus on patient safety, Avadel promotes responsible use of LUMRYZ through a restricted distribution program, ensuring that healthcare providers and pharmacists are specially certified. The company is committed to addressing the risks associated with central nervous system depression and potential abuse, while actively monitoring the emerging needs of their patient population. Generated from the website

Eclat Pharmaceuticals, L.L.C. is a specialty pharmaceutical company based in St. Louis, Missouri, dedicated to developing, approving, and commercializing niche brands and generic products. With a focus on improving patient outcomes, Eclat utilizes its expertise in the regulatory process, development, manufacturing, and distribution to find innovative and cost-effective solutions for drug delivery and side effect profiles. Through its strategic approach, Eclat has identified several promising product opportunities and is actively developing them. With the acquisition by Flamel Technologies SA in 2012, Eclat has become a more vertically integrated company, benefiting from enhanced development and commercial expertise, advanced drug delivery platforms, and increased potential for value creation.Generated from the website